<DOC>
	<DOCNO>NCT00615108</DOCNO>
	<brief_summary>The purpose observational study survey safety effectiveness product real condition usual practice Taiwanese hypertensive patient . During 8-week observation , safety profile clinical evaluation dose blood pressure ( BP ) measurement overall effectiveness telmisartan therapy conclude .</brief_summary>
	<brief_title>Nice Morning- Safety Efficacy Observational Study Telmisartan Hypertensive Patients Multicenters</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>1 . Male female . 2 . Aged 20 80 year old . 3 . Patients meet one follow two criterion : 1 . Adult essential hypertensive either newly diagnose untreated , previously treat uncontrolled patient ; sit blood pressure : systolic blood pressure ( BP ) &gt; 140 mmHg &lt; 180 mmHg , and/or diastolic BP &gt; 90 mmHg &lt; 110 mmHg ) . 2 . Patients assessed benefit intake angiotensin II receptor blocker ( ARB ) monotherapy addon medication . 1 . Patients contraindication telmisartan use ( per Micardis® Tablets package insert ) . 2 . Known hypersensitivity active ingredient excipients Micardis® Tablets . 3 . Any clinical condition , opinion attend physician , would allow safe administration study medication .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>